Connect Biopharma Holdings Limited enterprise value

The Enterprise Value as of November 2026 (TTM) for Connect Biopharma Holdings Limited (CNTB) is 23.75M

According to Connect Biopharma Holdings Limited’s latest financial reports and current stock price. The company's current Enterprise Value is 23.75M. This represents a change of -62.78% compared to the average of 63.82M of the last 4 quarters.

Connect Biopharma Holdings Limited (CNTB) Historical Enterprise Value (quarterly & annually)

How has CNTB Enterprise Value performed in the past?

The mean historical Enterprise Value of Connect Biopharma Holdings Limited over the last ten years is 259.23M. The current 23.75M Enterprise Value has changed -90.84% with respect to the historical average. Over the past ten years (40 quarters), CNTB's Enterprise Value was at its highest in in the June 2019 quarter at 1.02B. The Enterprise Value was at its lowest in in the December 2023 quarter at -40218940.00.

Connect Biopharma Holdings Limited (CNTB) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Connect Biopharma Holdings Limited Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Connect Biopharma Holdings Limited (CNTB) Average Enterprise Value

How has CNTB Enterprise Value performed in the past?

The current Enterprise Value of Connect Biopharma Holdings Limited (CNTB) is less than than its 3-year, greater than its 5-year, and less than than its 10-year historical averages

Connect Biopharma Holdings Limited (CNTB) Enterprise Value vs. Peers

How is CNTB’s Enterprise Value compared to its peers?

Connect Biopharma Holdings Limited’s Enterprise Value is less than InflaRx N.V. (77.69M), greater than ImageneBio Inc (-45145457.00), greater than Kalaris Therapeutics Inc (3.22M), less than Shattuck Labs, Inc. (486.86M), greater than Artiva Biotherapeutics, Inc. (-86677173.00), less than Sutro Biopharma, Inc. (107.01M), less than Metagenomi, Inc. Common Stock (28.19M), greater than Context Therapeutics Inc. (-25150517.00), greater than Quince Therapeutics, Inc. (-83689345.00), less than Ovid Therapeutics Inc. (497.44M),

Build a custom stock screener for Connect Biopharma Holdings Limited (CNTB) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Connect Biopharma Holdings Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Connect Biopharma Holdings Limited (CNTB) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Connect Biopharma Holdings Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.